Filing Details

Accession Number:
0000711377-13-000010
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-04-05 17:19:06
Reporting Period:
2013-04-04
Filing Date:
2013-04-05
Accepted Time:
2013-04-05 17:19:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-04-04 16,000 $18.19 603,209 No 4 M Direct
Common Stock Disposition 2013-04-04 16,000 $49.50 587,209 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2013-04-04 16,000 $0.00 16,000 $18.19
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
245,608 2013-08-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 252,320 Indirect See Footnote
Footnotes
  1. Options were granted to Mr. Herbert on 8/15/2008, vest on five equal annual installments on the anniversary date of the grant, and expire on 8/15/2013
  2. 120,000 shares are held in a limited liability corporation, of which Mr. Herbert is the sole owner, and 132,320 shares are held in trust for Judith Herbert, spouse of Mr. Herbert